Heart failure drug put to the test in major chinese Real-World study
NCT ID NCT05728502
Summary
This study collected real-world data on vericiguat, a medication for chronic heart failure, in China. Researchers compared 2,400 patients taking vericiguat with similar patients receiving standard care to see which group had fewer hospitalizations and deaths from heart problems. The goal was to understand how well the medication works in everyday medical practice outside of strict clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese Registries
Multiple Locations, Many Locations, China
Conditions
Explore the condition pages connected to this study.